Global /United States /Healthcare /Medical Care Facilities /IVF

INVO Fertility, Inc.

IVF

• NASDAQ: IVF • Delayed

1.92USD -1%

As of 13 June 2026, INVO Fertility, Inc. has a market cap of $3.1M USD, ranking #46064 globally and #5847 in the United States. It ranks #4085 in the Healthcare sector, and #484 in the Medical Care Facilities industry.

Global Rank

46064

Country Rank

5847

Sector Rank

4085

Industry Rank

484

Key Stats

Market Cap

$3.1MUSD

Enterprise Value

$6.93MUSD

Revenue (TTM)

$6.94MUSD

EBITDA (TTM)

-$7.12MUSD

Net Income (TTM)

-$29.21MUSD

EBITDA Margin

-103%

PS Ratio

0.4

PB Ratio

0.5

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Steven Shum open_in_new

Employees

Founded

2007

Website

invobioscience.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1%	-15%	-28%	-76%	-91%	-49%	-99%	-100%	-100%

News

IVF Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	IVF ISIN: US44984F8804 Shares Out.: Shares Outstanding: 1.786M¹ Shares Float: 1.779M² TV: TradingView: NASDAQ: IVF SA: Stock Analysis: NASDAQ: IVF YF: Yahoo Finance: IVF GF: Google Finance: NASDAQ: IVF NQ: NASDAQ: IVF BA: Barron's: IVF MS: Morningstar: XNAS: IVF	1.92 USD	TV: TradingView: NASDAQ: IVF SA: Stock Analysis: NASDAQ: IVF YF: Yahoo Finance: IVF GF: Google Finance: NASDAQ: IVF NQ: NASDAQ: IVF BA: Barron's: IVF MS: Morningstar: XNAS: IVF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About INVO Fertility, Inc.

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Similar Companies

Industry: Medical Care Facilities (United States)

Name	Market Cap (USD) diff.	PE	Country
HCA Healthcare, Inc. NYSE: HCA	$96.73B 3M%	14.9	United States
Labcorp Holdings Inc. NYSE: LH	$21.13B 681K%	24.6	United States
Tenet Healthcare Corp. NYSE: THC	$15.78B 509K%	11.6	United States
Solventum Corp. NYSE: SOLV	$11.53B 372K%	7.5	United States
The Ensign Group, Inc. NASDAQ: ENSG	$10.89B 351K%	31.9	United States
Universal Health Services, Inc. NYSE: UHS	$10.25B 330K%	6.8	United States

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 7M%	44.1	United Arab Emirates
Fresenius SE & Co. KGaA XETRA: FRE	$26.55B 22.97B EUR 856K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.45B 22.02B EUR 821K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 725K%	35.2	Saudi Arabia
IHH Healthcare Bhd. MYX: 5225	$19.14B 77.85B MYR 617K%	37.0	Malaysia
Rede D'Or São Luiz S.A. BVMF: RDOR3	$16.69B 84.79B BRL 538K%	18.1	Brazil

chevron_leftBack